SRSensus Healthcare, Inc. SRTS · NASDAQ
$2.86 +4.00% (+$0.11)
- Market cap
- $47.1M
- Enterprise value
- $32.2M
- P/E
- -
- Forward P/E
- -
- PEG
- -
- P/S
- 2.7x
- P/FCF
- -
- EV/EBITDA
- -
- ROIC
- -43.4%
- Gross margin
- 36.4%
- Net margin
- -88.5%
- Dividend yield
- -
- Payout ratio
- -
- Net debt/EBITDA
- -
- Beta
- 1.19
- Free float
- 81.3%
About the company
Sensus Healthcare, Inc. (SRTS) is a company specializing in the development and provision of advanced technologies for the treatment of cancer and dermatological conditions. With over a decade of history, Sensus Healthcare focuses on innovative approaches, such as low-dose radiation therapy, that selectively target tumor cells and minimize effects on surrounding healthy tissues. Their technologies offer patients and physicians alternative treatment options with an emphasis on effectiveness and reduced invasiveness. Sensus Healthcare, Inc. (SRTS) contributes to the advancement of sophisticated treatment methods and the improvement of quality of life for patients with cancer and dermatological conditions. Sensus Healthcare, Inc. (SRTS) shares could be suitable for investors who want to support innovations in oncological and dermatological treatment and contribute to progress in therapeutic approaches.
Sector
Healthcare
Industry
Medical - Devices
CEO
Joseph C. Sardano
Employees
60
Headquarters
Boca Raton
Valuation
Is today's price reasonable?
Growth and estimates
Is it growing, and what comes next?
Profitability and quality
How much of the revenue is left, and how well does the company use its capital?
Financial health
Can it carry its debt?
Capital and dividends
What does the company do with the money it earns?
Analysts
What do the professionals think, and is it changing?
Owners and insiders
Who holds the stock, and what is management doing?
Segments
Which part of the company is growing?
Peer comparison
How does it compare with similar companies?
Price and risk
How does the stock behave?
Statements
Every number